At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
“OUR TAKE: 2026 will be another big year for the obesity market, with the launch of oral GLP-1s from LLY and NVO, better ...
We recently published 12 Stocks on Jim Cramer’s Radar. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer’s radar.
Athira Pharma has joined an attempt to rescue an asset abandoned by Pfizer. The biotech has secured near-global rights to a phase 3 breast cancer prospect in a deal with Sermonix Pharmaceuticals.
Pfizer Inc. is rated a Hold due to structural challenges despite recent 12% total return and compelling 6.7% dividend yield.
On December 16, 2025, Pfizer announced its financial guidance for the full year 2026, while revising its 2025 revenue guidance to approximately $62.0 billion. The company expects 2026 revenues to ...
Tilray Brands jumped 27.54% to close at $13.94, after trading between an intraday low of $10.50 and a high of $14.55; the ...
Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to ...
Pfizer said on Tuesday the next few years will be bumpy, beginning with 2026, due to lower sales of its COVID vaccine and ...
Investor's Business Daily on MSN
Why Pfizer's 2026 guidance miss is 'not a major surprise'
PfizerPFE stock tumbled Tuesday, crashing into its 50-day line, after the drugmaker missed Wall Street's earnings forecast ...
Pfizer said revenue should come in at the lower end of its guidance for this year, while it expects less revenue in 2026 than in 2025, as the drugmaker's efforts to remake its business continue to ...
Pfizer on Tuesday forecast 2026 profit below Wall Street estimates, sending its shares down 1. The drugmaker expects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback